Immutep Secures Second European Patent For Eftilagimod Alpha, A Soluble LAG-3 Protein, In Combination With A PD-1 Pathway Inhibitor

David Linetsky
Point-of-Care Marketing

Suma Ramadas, PhD
Medical Affairs

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Pat Purcell
Meeting Engagement

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement

Matthew Durham
Omnidynamic Marketing